Evoke Pharma Net Change in Intangible Assets 2012-2025 | EVOK

Evoke Pharma net change in intangible assets from 2012 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.

Evoke Pharma Net Change in Intangible Assets 2012-2025 | EVOK

Evoke Pharma net change in intangible assets from 2012 to 2025. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$21.1B
Dr Reddy's Laboratories (RDY)$11.9B
BridgeBio Pharma (BBIO)$9.9B
Bausch Health Cos (BHC)$2.7B
Supernus Pharmaceuticals (SUPN)$2.5B
Amphastar Pharmaceuticals (AMPH)$1.4B
Taysha Gene Therapies (TSHA)$797M
Personalis (PSNL)$434M
Assembly Biosciences (ASMB)$190M
Sol-Gel Technologies (SLGL)$63M
Teligent (TLGT)$0M